FMCSA Grants Seizure-Disorder Exemptions to 63 Commercial Drivers
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This notice allows 63 named interstate commercial vehicle drivers with a history of seizures, who are taking anti-seizure medication, to keep operating commercial motor vehicles despite the usual medical disqualification rule. The exemptions are limited to these individuals and run from March 4, 2026, through March 4, 2028. Motor carriers employing these drivers should confirm that each driver’s exemption remains valid and that any required medical conditions are followed.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Grants medical exemptions to 63 interstate commercial vehicle drivers with seizure histories
- Allows the exempted drivers to operate commercial motor vehicles while taking anti-seizure medication
- Sets the exemption period from March 4, 2026, to March 4, 2028
Obligations
What this law requires
Motor carriers employing any of the 63 named interstate CMV drivers covered by this FMCSA notice should verify that the individual driver’s seizure-disorder exemption is valid before allowing the driver to operate a commercial motor vehicle in interstate commerce.
Covered drivers may operate commercial motor vehicles in interstate commerce only during the exemption period running from March 4, 2026 through March 4, 2028, unless FMCSA grants a further exemption or renewal.
Motor carriers should ensure that any medical conditions attached to a covered driver’s FMCSA seizure-disorder exemption are followed while the driver operates a commercial motor vehicle in interstate commerce.